Group is attractive because it possesses two rare qualities for a drugmaker: strong growth in existing products and a rich pipeline of new products Source
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,